newsfilter
← Latest News
PR Newswire·

Mallinckrodt to Report Earnings Results for Fourth Quarter 2022

DUBLIN, Feb. 8, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE:MNK), a global specialty pharmaceutical company, today announced that it will report fourth quarter 2022 earnings results for the period ended December 30,